| Year |
Citation |
Score |
| 2020 |
Davies RA, Baird TR, Nguyen VT, Ruiz B, Sakloth F, Eltit JM, Negus SS, Glennon RA. An investigation of the optical isomers of methcathinone (MCAT), and two achiral analogs, at monoamine transporters and in intracranial self- stimulation studies in rats. Acs Chemical Neuroscience. PMID 32356961 DOI: 10.1021/acschemneuro.9b00617 |
0.48 |
|
| 2019 |
Shah UH, Gaitonde SA, Moreno JL, Glennon RA, Dukat M, González-Maeso J. A revised pharmacophore model for 5-HT2A receptor antagonists derived from the atypical antipsychotic agent risperidone. Acs Chemical Neuroscience. PMID 30609893 DOI: 10.1021/acschemneuro.8b00637 |
0.64 |
|
| 2018 |
Walther D, Shalabi AR, Baumann MH, Glennon RA. Systematic structure-activity studies on selected 2-, 3-, and 4-monosubstituted synthetic methcathinone analogs as monoamine transporter releasing agents. Acs Chemical Neuroscience. PMID 30354055 DOI: 10.1021/acschemneuro.8b00524 |
0.48 |
|
| 2018 |
Dukat M, Jain AD, German N, Ferrara-Pontoriero R, Huang Y, Ma Y, Schulte MK, Glennon RA. des-Formylflustrabromine (dFBr): A Structure-Activity Study on its Ability to Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors. Acs Chemical Neuroscience. PMID 30028943 DOI: 10.1021/acschemneuro.8b00156 |
0.64 |
|
| 2018 |
Battisti UM, Sitta R, Harris A, Sakloth F, Walther D, Ruchala I, Negus S, Baumann MH, Glennon RA, Eltit JM. Effects of N-alkyl-4-methylamphetamine optical isomers on plasma membrane monoamine transporters and abuse-related behavior. Acs Chemical Neuroscience. PMID 29697951 DOI: 10.1021/acschemneuro.8b00138 |
0.48 |
|
| 2017 |
Glennon RA, Dukat M. Synthetic Cathinones: A Brief Overview of Overviews with Applications to the Forensic Sciences. Annals of Forensic Research and Analysis. 4. PMID 30288398 |
0.64 |
|
| 2017 |
Solis E, Partilla JS, Sakloth F, Ruchala I, Schwienteck KL, De Felice LJ, Eltit JM, Glennon RA, Negus SS, Baumann MH. N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28530234 DOI: 10.1038/npp.2017.98 |
0.48 |
|
| 2017 |
Shalabi AR, Walther D, Baumann MH, Glennon RA. Deconstructed analogs of bupropion reveal structural requirements for transporter inhibition versus substrate-induced neurotransmitter release. Acs Chemical Neuroscience. PMID 28220701 DOI: 10.1021/acschemneuro.7b00055 |
0.48 |
|
| 2016 |
Glennon RA, Dukat M. Structure-Activity Relationships of Synthetic Cathinones. Current Topics in Behavioral Neurosciences. PMID 27830576 DOI: 10.1007/7854_2016_41 |
0.64 |
|
| 2016 |
Younkin J, Gaitonde SA, Ellaithy A, Vekariya RH, Baki L, Moreno JL, Shah S, Drossopoulos P, Hideshima KS, Eltit JM, González-Maeso J, Logothetis DE, Dukat M, Glennon RA. Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists. Acs Chemical Neuroscience. PMID 27385190 DOI: 10.1021/acschemneuro.6b00162 |
1 |
|
| 2016 |
Glennon RA, Young R. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP). Brain Research Bulletin. PMID 27142261 DOI: 10.1016/j.brainresbull.2016.04.011 |
0.76 |
|
| 2016 |
Suyama JA, Sakloth F, Kolanos R, Glennon RA, Lazenka MF, Negus SS, Banks ML. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin. The Journal of Pharmacology and Experimental Therapeutics. 356: 182-90. PMID 26645638 DOI: 10.1124/jpet.115.229559 |
0.56 |
|
| 2015 |
Hutsell BA, Baumann MH, Partilla JS, Banks ML, Vekariya R, Glennon RA, Negus SS. Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26738428 DOI: 10.1016/j.euroneuro.2015.12.010 |
0.48 |
|
| 2015 |
May JA, Sharif NA, McLaughlin MA, Chen HH, Severns BS, Kelly CR, Holt WF, Young R, Glennon RA, Hellberg MR, Dean TR. Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a Selective 5-HT2 Receptor Agonist. Journal of Medicinal Chemistry. PMID 26551970 DOI: 10.1021/acs.jmedchem.5b00857 |
0.76 |
|
| 2015 |
Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine. Bioorganic & Medicinal Chemistry. 23: 5574-9. PMID 26233799 DOI: 10.1016/j.bmc.2015.07.035 |
0.48 |
|
| 2015 |
Kolanos R, Sakloth F, Jain AD, Partilla JS, Baumann MH, Glennon RA. Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters. Acs Chemical Neuroscience. PMID 26217965 DOI: 10.1021/acschemneuro.5b00160 |
1 |
|
| 2015 |
Hamouda AK, Wang ZJ, Stewart DS, Jain AD, Glennon RA, Cohen JB. Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor. Molecular Pharmacology. 88: 1-11. PMID 25870334 DOI: 10.1124/mol.115.098913 |
0.48 |
|
| 2015 |
Kolanos R, Partilla JS, Baumann MH, Hutsell BA, Banks ML, Negus SS, Glennon RA. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats. Acs Chemical Neuroscience. 6: 771-7. PMID 25688761 DOI: 10.1021/acschemneuro.5b00006 |
1 |
|
| 2015 |
Tang QY, Kolanos R, De Felice LJ, Glennon RA. Structural analysis of dopamine- and amphetamine-induced depolarization currents in the human dopamine transporter. Acs Chemical Neuroscience. 6: 551-8. PMID 25594379 DOI: 10.1021/cn500282f |
1 |
|
| 2015 |
Sakloth F, Kolanos R, Mosier PD, Bonano JS, Banks ML, Partilla JS, Baumann MH, Negus SS, Glennon RA. Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. British Journal of Pharmacology. 172: 2210-8. PMID 25522019 DOI: 10.1111/bph.13043 |
1 |
|
| 2015 |
Bonano JS, Banks ML, Kolanos R, Sakloth F, Barnier ML, Glennon RA, Cozzi NV, Partilla JS, Baumann MH, Negus SS. Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. British Journal of Pharmacology. 172: 2433-44. PMID 25438806 DOI: 10.1111/bph.13030 |
1 |
|
| 2015 |
Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine Bioorganic and Medicinal Chemistry. DOI: 10.1016/j.bmc.2015.07.035 |
1 |
|
| 2014 |
Bonano JS, Runyon SP, Hassler C, Glennon RA, Stevens Negus S. Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats. European Journal of Pharmacology. 743: 98-105. PMID 25220242 DOI: 10.1016/j.ejphar.2014.09.006 |
0.4 |
|
| 2014 |
Rao BK, Samanta D, Joshi S, Basu K, Baldwin SD, Jha A, Dukat M, Glennon RA, Jena P. Receptor-ligand interaction at 5-HT3 serotonin receptors: a cluster approach. The Journal of Physical Chemistry. A. 118: 8471-6. PMID 24878072 DOI: 10.1021/jp5017906 |
1 |
|
| 2014 |
Ruchala I, Cabra V, Solis E, Glennon RA, De Felice LJ, Eltit JM. Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels. Cell Calcium. 56: 25-33. PMID 24854234 DOI: 10.1016/j.ceca.2014.04.003 |
1 |
|
| 2014 |
Glennon RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Advances in Pharmacology (San Diego, Calif.). 69: 581-620. PMID 24484988 DOI: 10.1016/B978-0-12-420118-7.00015-9 |
1 |
|
| 2014 |
De Felice LJ, Glennon RA, Negus SS. Synthetic cathinones: Chemical phylogeny, physiology, and neuropharmacology Life Sciences. 97: 20-26. PMID 24231923 DOI: 10.1016/j.lfs.2013.10.029 |
1 |
|
| 2014 |
Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS. Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology. 231: 199-207. PMID 23949206 DOI: 10.1007/s00213-013-3223-5 |
1 |
|
| 2014 |
Bonano JS, Runyon SP, Hassler C, Glennon RA, Stevens Negus S. Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats European Journal of Pharmacology. 743: 98-105. DOI: 10.1016/j.ejphar.2014.09.006 |
1 |
|
| 2014 |
Glennon RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention Advances in Pharmacology. 69: 583-620. DOI: 10.1016/B978-0-12-420118-7.00015-9 |
1 |
|
| 2013 |
Kolanos R, Solis E, Sakloth F, De Felice LJ, Glennon RA. "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. Acs Chemical Neuroscience. 4: 1524-9. PMID 24116392 DOI: 10.1021/cn4001236 |
1 |
|
| 2013 |
Cameron K, Kolanos R, Verkariya R, De Felice L, Glennon RA. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter Psychopharmacology. 227: 493-499. PMID 23371489 DOI: 10.1007/s00213-013-2967-2 |
1 |
|
| 2013 |
Cameron KN, Kolanos R, Solis E, Glennon RA, De Felice LJ. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. British Journal of Pharmacology. 168: 1750-7. PMID 23170765 DOI: 10.1111/bph.12061 |
1 |
|
| 2011 |
German N, Kim JS, Jain A, Dukat M, Pandya A, Ma Y, Weltzin M, Schulte MK, Glennon RA. Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine Journal of Medicinal Chemistry. 54: 7259-7267. PMID 21905680 DOI: 10.1021/jm200834x |
1 |
|
| 2011 |
Zhang X, Andren PE, Glennon RA, Svenningsson P. Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. The Journal of Comparative Neurology. 519: 1816-27. PMID 21452237 DOI: 10.1002/cne.22605 |
1 |
|
| 2011 |
Klein MT, Dukat M, Glennon RA, Teitler M. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. The Journal of Pharmacology and Experimental Therapeutics. 337: 860-7. PMID 21422162 DOI: 10.1124/jpet.111.179606 |
1 |
|
| 2011 |
Glennon RA, Young R. Drug Discrimination and Development of Novel Agents and Pharmacological Tools Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 217-233. DOI: 10.1002/9781118023150.ch7 |
1 |
|
| 2011 |
Glennon RA, Young R. Drug Discrimination and Mechanisms of Drug Action Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 183-216. DOI: 10.1002/9781118023150.ch6 |
1 |
|
| 2011 |
Glennon RA, Young R. Drug Discrimination and In Vivo Structure-Activity Relationships Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 163-181. DOI: 10.1002/9781118023150.ch5 |
1 |
|
| 2011 |
Glennon RA, Young R. Role of Stereochemistry in Drug Discrimination Studies Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 129-161. DOI: 10.1002/9781118023150.ch4 |
1 |
|
| 2011 |
Glennon RA, Young R. Drug Discrimination: Practical Considerations Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 41-128. DOI: 10.1002/9781118023150.ch3 |
1 |
|
| 2011 |
Glennon RA, Young R. Methodological Considerations Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 19-40. DOI: 10.1002/9781118023150.ch2 |
1 |
|
| 2011 |
Glennon RA, Young R. An Introduction to Drug Discrimination Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. 3-17. DOI: 10.1002/9781118023150.ch1 |
1 |
|
| 2011 |
Glennon RA, Young R. Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies. DOI: 10.1002/9781118023150 |
1 |
|
| 2010 |
Dukat M, Wesolowska A, Alley G, Young S, Abdrakhmanova GR, Navarro HA, Young R, Glennon RA. MD-354 selectively antagonizes the antinociceptive effects of (-)nicotine in the mouse tail-flick assay Psychopharmacology. 210: 547-557. PMID 20431995 DOI: 10.1007/s00213-010-1857-0 |
1 |
|
| 2010 |
Glennon RA, Siripurapu U, Roth BL, Kolanos R, Bondarev ML, Sikazwe D, Lee M, Dukat M. The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs. Current Topics in Medicinal Chemistry. 10: 579-95. PMID 20166945 DOI: 10.2174/156802610791111542 |
1 |
|
| 2010 |
Giorgioni G, Claudi F, Ruggieri S, Ricciutelli M, Palmieri GF, Stefano AD, Sozio P, Cerasa LS, Chiavaroli A, Ferrante C, Orlando G, Glennon RA. Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as l-DOPA prodrugs Bioorganic and Medicinal Chemistry. 18: 1834-1843. PMID 20153654 DOI: 10.1016/j.bmc.2010.01.041 |
1 |
|
| 2010 |
Abate C, Elenewski J, Niso M, Berardi F, Colabufo NA, Azzariti A, Perrone R, Glennon RA. Interaction of the σ2 receptor ligand PB28 with the human nucleosome: Computational and experimental probes of interaction with the H2A/H2B dimer Chemmedchem. 5: 268-273. PMID 20077462 DOI: 10.1002/cmdc.200900402 |
1 |
|
| 2009 |
Abate C, Mosier PD, Berardi F, Glennon RA. A structure-affinity and comparative molecular field analysis of sigma-2 (σ2) receptor ligands Central Nervous System Agents in Medicinal Chemistry. 9: 246-257. PMID 20021358 |
1 |
|
| 2009 |
Glennon RA. The enigmatic sigma receptors Central Nervous System Agents in Medicinal Chemistry. 9: 159-160. PMID 20021349 DOI: 10.2174/1871524910909030159 |
1 |
|
| 2009 |
Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, et al. Predicting new molecular targets for known drugs. Nature. 462: 175-81. PMID 19881490 DOI: 10.1038/nature08506 |
1 |
|
| 2009 |
Young R, Glennon RA. S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats Psychopharmacology. 203: 369-382. PMID 18795268 DOI: 10.1007/s00213-008-1317-2 |
1 |
|
| 2009 |
Khorana N, Young R, Glennon RA. Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats Pharmacology Biochemistry and Behavior. 91: 385-392. PMID 18778728 DOI: 10.1016/j.pbb.2008.08.013 |
1 |
|
| 2009 |
May JA, Sharif NA, Chen HH, Liao JC, Kelly CR, Glennon RA, Young R, Li JX, Rice KC, France CP. Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]. Pharmacology, Biochemistry, and Behavior. 91: 307-14. PMID 18718483 DOI: 10.1016/j.pbb.2008.07.015 |
1 |
|
| 2008 |
Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation. Journal of Medicinal Chemistry. 51: 6808-28. PMID 18847250 DOI: 10.1021/jm800771x |
1 |
|
| 2008 |
Dukat M, Mosier PD, Kolanos R, Roth BL, Glennon RA. Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies. Journal of Medicinal Chemistry. 51: 603-11. PMID 18201064 DOI: 10.1021/jm070910s |
1 |
|
| 2008 |
Young R, Glennon RA. MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice Pharmacology Biochemistry and Behavior. 88: 318-331. PMID 17904622 DOI: 10.1016/j.pbb.2007.09.002 |
1 |
|
| 2007 |
Kim JS, Padnya A, Weltzin M, Edmonds BW, Schulte MK, Glennon RA. Synthesis of desformylflustrabromine and its evaluation as an α4β2 and α7 nACh receptor modulator Bioorganic and Medicinal Chemistry Letters. 17: 4855-4860. PMID 17604168 DOI: 10.1016/j.bmcl.2007.06.047 |
1 |
|
| 2007 |
Dukat M, Wesolowska A, Young R, Glennon RA. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats Pharmacology Biochemistry and Behavior. 87: 203-207. PMID 17540440 DOI: 10.1016/j.pbb.2007.03.008 |
1 |
|
| 2007 |
Dukat M, Glennon RA, Young S. MD-354: What is it good for? Cns Drug Reviews. 13: 1-20. PMID 17461887 DOI: 10.1111/j.1527-3458.2007.00002.x |
1 |
|
| 2007 |
Glennon RA, Young R, Dukat M, Chang-Fong J, El-Zahabi M. N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats Pharmacology Biochemistry and Behavior. 86: 477-484. PMID 17307247 DOI: 10.1016/j.pbb.2007.01.007 |
1 |
|
| 2007 |
Nyandege A, Kolanos R, Roth BL, Glennon RA. Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors. Bioorganic & Medicinal Chemistry Letters. 17: 1691-4. PMID 17239595 DOI: 10.1016/j.bmcl.2006.12.089 |
1 |
|
| 2007 |
De Oliveira EO, Brandt CA, Da Silveira MAB, Glennon RA. Synthesis of pyrrolidine-substituted benzamides via iodocyclization of β-enaminoesters Tetrahedron Letters. 48: 6393-6396. DOI: 10.1016/j.tetlet.2007.06.166 |
1 |
|
| 2007 |
Ablordeppey SY, Glennon RA. Pharmacophore models for σ1 receptor binding Sigma Receptors: Chemistry, Cell Biology and Clinical Implications. 71-98. DOI: 10.1007/978-0-387-36514-5_4 |
1 |
|
| 2006 |
Glennon RA, Bondareva T, Young R. α-Ethyltryptamine (α-ET) as a discriminative stimulus in rats Pharmacology Biochemistry and Behavior. 85: 448-453. PMID 17112572 DOI: 10.1016/j.pbb.2006.09.014 |
1 |
|
| 2006 |
Young R, Bondareva T, Wesolowska A, Young S, Glennon RA. Effect of the 5-HT6 serotonin antagonist MS-245 on the actions of (-)nicotine Pharmacology Biochemistry and Behavior. 85: 170-177. PMID 16950502 DOI: 10.1016/j.pbb.2006.07.029 |
1 |
|
| 2006 |
Kolanos R, Dukat M, Roth BL, Glennon RA. Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors. Bioorganic & Medicinal Chemistry Letters. 16: 5832-5. PMID 16945532 DOI: 10.1016/j.bmcl.2006.08.068 |
1 |
|
| 2006 |
Sikazwe D, Bondarev ML, Dukat M, Rangisetty JB, Roth BL, Glennon RA. Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors. Journal of Medicinal Chemistry. 49: 5217-25. PMID 16913710 DOI: 10.1021/jm060469q |
1 |
|
| 2006 |
Ragab HM, Kim JS, Dukat M, Navarro H, Glennon RA. Aryloxyethylamines: Binding at α7 nicotinic acetylcholine receptors Bioorganic and Medicinal Chemistry Letters. 16: 4283-4286. PMID 16765047 DOI: 10.1016/j.bmcl.2006.05.080 |
1 |
|
| 2006 |
Young R, Batkai S, Dukat M, Glennon RA. TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice Pharmacology Biochemistry and Behavior. 84: 62-73. PMID 16750844 DOI: 10.1016/j.pbb.2006.04.006 |
1 |
|
| 2006 |
Young R, Rothman RB, Rangisetty JB, Partilla JS, Dukat M, Glennon RA. TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline) inhibits the consumption of "snacks" in mice Pharmacology Biochemistry and Behavior. 84: 74-83. PMID 16750261 DOI: 10.1016/j.pbb.2006.04.007 |
1 |
|
| 2006 |
Siripurapu U, Kolanos R, Dukat M, Roth BL, Glennon RA. Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 16: 3793-6. PMID 16709453 DOI: 10.1016/j.bmcl.2006.04.094 |
1 |
|
| 2006 |
Young R, Bondareva T, Wesolowska A, Glennon RA. Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT) Pharmacology Biochemistry and Behavior. 83: 612-617. PMID 16675002 DOI: 10.1016/j.pbb.2006.03.025 |
1 |
|
| 2006 |
Glennon RA. 3-(4-(Tetrahydropyridin-1-yl) butyl) oxindoles as 5-HT 7 receptor Expert Opinion On Therapeutic Patents. 16: 1171-1174. DOI: 10.1517/13543776.16.8.1171 |
1 |
|
| 2005 |
Bondareva T, Weso?owska A, Dukat M, Lee M, Young R, Glennon RA. S(+)- and R(-)N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: Effect of cocaine Pharmacology Biochemistry and Behavior. 82: 531-538. PMID 16337676 DOI: 10.1016/j.pbb.2005.10.008 |
1 |
|
| 2005 |
Young R, Khorana N, Bondareva T, Glennon RA. Pizotyline effectively attenuates the stimulus effects of N-Methyl-3,4-methylenedioxyamphetamine (MDMA) Pharmacology Biochemistry and Behavior. 82: 404-410. PMID 16253319 DOI: 10.1016/j.pbb.2005.09.010 |
1 |
|
| 2005 |
Glennon RA. Pharmacophore identification for sigma-1 (σ1) receptor binding: Application of the "Deconstruction - Reconstruction - Elaboration" approach Mini-Reviews in Medicinal Chemistry. 5: 927-940. PMID 16250835 DOI: 10.2174/138955705774329519 |
1 |
|
| 2005 |
Pullagurla M, Siripurapu U, Kolanos R, Bondarev ML, Dukat M, Setola V, Roth BL, Glennon RA. Binding of amine-substituted N1-benzenesulfonylindoles at human 5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 15: 5298-302. PMID 16183286 DOI: 10.1016/j.bmcl.2005.08.059 |
1 |
|
| 2005 |
Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA. 3-(2-Aminoethyl)pyridine analogs as α4β2 nicotinic cholinergic receptor ligands Bioorganic and Medicinal Chemistry Letters. 15: 4308-4312. PMID 16039854 DOI: 10.1016/j.bmcl.2005.06.053 |
1 |
|
| 2005 |
Abate C, Kolanos R, Dukat M, Setola V, Roth BL, Glennon RA. Interaction of chiral MS-245 analogs at h5-HT6 receptors. Bioorganic & Medicinal Chemistry Letters. 15: 3510-3. PMID 15990303 DOI: 10.1016/j.bmcl.2005.05.092 |
1 |
|
| 2005 |
Ramunno A, Dukat M, Lee M, Young R, El-Zahabi M, Damaj MI, Martin B, Glennon RA. 6-(2-Phenylethyl)nicotine: A novel nicotinic cholinergic receptor ligand Bioorganic and Medicinal Chemistry Letters. 15: 3237-3240. PMID 15925512 DOI: 10.1002/CHIN.200543161 |
1 |
|
| 2005 |
Ramunno A, Dukat M, Lee M, Young R, El-Zahabi M, Damaj MI, Martin B, Glennon RA. 6-(2-Phenylethyl)nicotine: A novel nicotinic cholinergic receptor ligand Bioorganic and Medicinal Chemistry Letters. 15: 3237-3240. PMID 15925512 DOI: 10.1002/CHIN.200543161 |
1 |
|
| 2005 |
Setola V, Dukat M, Glennon RA, Roth BL. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor. Molecular Pharmacology. 68: 20-33. PMID 15831837 DOI: 10.1124/mol.104.009266 |
1 |
|
| 2005 |
Kolanos R, Siripurapu U, Pullagurla M, Riaz M, Setola V, Roth BL, Dukat M, Glennon RA. Binding of isotryptamines and indenes at h5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 15: 1987-91. PMID 15808453 DOI: 10.1016/j.bmcl.2005.02.070 |
1 |
|
| 2005 |
Kolanos R, Siripurapu U, Pullagurla M, Riaz M, Setola V, Roth BL, Dukat M, Glennon RA. Binding of isotryptamines and indenes at h5-HT6 serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 15: 1987-91. PMID 15808453 DOI: 10.1016/j.bmcl.2005.02.070 |
1 |
|
| 2005 |
Lee M, Rangisetty JB, Pullagurla MR, Dukat M, Setola V, Roth BL, Glennon RA. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Bioorganic & Medicinal Chemistry Letters. 15: 1707-11. PMID 15745826 DOI: 10.1016/j.bmcl.2005.01.031 |
1 |
|
| 2005 |
Lee M, Rangisetty JB, Pullagurla MR, Dukat M, Setola V, Roth BL, Glennon RA. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Bioorganic & Medicinal Chemistry Letters. 15: 1707-11. PMID 15745826 DOI: 10.1016/j.bmcl.2005.01.031 |
1 |
|
| 2005 |
Pullagurla M, Dukat M, Roth BL, Setola V, Glennon RA. 5-Azatryptamine analogs as h5-HT6 serotonin receptor ligands Medicinal Chemistry Research. 14: 1-18. DOI: 10.1007/s00044-004-0121-8 |
1 |
|
| 2005 |
Glennon RA. Binding characteristics of σ2 receptor ligands Revista Brasileira De Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences. 41: 1-12. |
1 |
|
| 2004 |
Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, McLaughlin MA, Sharif NA. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 47: 6034-41. PMID 15537358 DOI: 10.1021/jm040082s |
1 |
|
| 2004 |
Glennon RA, Bondarev ML, Khorana N, Young R, May JA, Hellberg MR, McLaughlin MA, Sharif NA. Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 47: 6034-41. PMID 15537358 DOI: 10.1021/jm040082s |
1 |
|
| 2004 |
Pullagurla MR, Westkaemper RB, Glennon RA. Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors Bioorganic and Medicinal Chemistry Letters. 14: 4569-4573. PMID 15357994 DOI: 10.1016/j.bmcl.2004.05.076 |
1 |
|
| 2004 |
Pullagurla MR, Westkaemper RB, Glennon RA. Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors Bioorganic and Medicinal Chemistry Letters. 14: 4569-4573. PMID 15357994 DOI: 10.1016/j.bmcl.2004.05.076 |
0.36 |
|
| 2004 |
Prisinzano T, Dukat M, Law H, Slassi A, MacLean N, DeLannoy I, Glennon RA. 2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT 1D serotonin receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 4697-4699. PMID 15324890 DOI: 10.1016/j.bmcl.2004.06.085 |
1 |
|
| 2004 |
Khorana N, Pullagurla MR, Dukat M, Young R, Glennon RA. Stimulus effects of three sulfur-containing psychoactive agents Pharmacology Biochemistry and Behavior. 78: 821-826. PMID 15301941 DOI: 10.1016/j.pbb.2004.05.021 |
1 |
|
| 2004 |
Khorana N, Pullagurla MR, Dukat M, Young R, Glennon RA. Stimulus effects of three sulfur-containing psychoactive agents Pharmacology Biochemistry and Behavior. 78: 821-826. PMID 15301941 DOI: 10.1016/j.pbb.2004.05.021 |
0.44 |
|
| 2004 |
Pullagurla M, Bondareva T, Young R, Glennon RA. Modulation of the stimulus effects of (+)amphetamine by the 5-HT 6 antagonist MS-245 Pharmacology Biochemistry and Behavior. 78: 263-268. PMID 15219766 DOI: 10.1016/j.pbb.2004.03.017 |
1 |
|
| 2004 |
Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA. (+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 14: 3651-4. PMID 15203136 DOI: 10.1016/j.bmcl.2004.05.020 |
1 |
|
| 2004 |
Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA. (+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 14: 3651-4. PMID 15203136 DOI: 10.1016/j.bmcl.2004.05.020 |
1 |
|
| 2004 |
Khorana N, Pullagurla MR, Young R, Glennon RA. Comparison of the discriminative stimulus effects of 3,4- methylenedioxymethamphetamine (MDMA) and cocaine: Asymmetric generalization Drug and Alcohol Dependence. 74: 281-287. PMID 15194206 DOI: 10.1016/j.drugalcdep.2004.01.005 |
1 |
|
| 2004 |
Khorana N, Pullagurla MR, Young R, Glennon RA. Comparison of the discriminative stimulus effects of 3,4- methylenedioxymethamphetamine (MDMA) and cocaine: Asymmetric generalization Drug and Alcohol Dependence. 74: 281-287. PMID 15194206 DOI: 10.1016/j.drugalcdep.2004.01.005 |
0.44 |
|
| 2004 |
Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA. Binding of tryptamine analogs at h5-HT1E receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry. 12: 2545-2552. PMID 15110837 DOI: 10.1016/j.bmc.2004.03.026 |
1 |
|
| 2004 |
Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA. Binding of tryptamine analogs at h5-HT1E receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry. 12: 2545-2552. PMID 15110837 DOI: 10.1016/j.bmc.2004.03.026 |
0.44 |
|
| 2004 |
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. 14: 2279-83. PMID 15081025 DOI: 10.1016/j.bmcl.2004.02.014 |
1 |
|
| 2004 |
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. 14: 2279-83. PMID 15081025 DOI: 10.1016/j.bmcl.2004.02.014 |
1 |
|
| 2004 |
Glennon RA, Ismaiel AM, Ablordeppey S, El-Ashmawy M, Fisher JB. Thioxanthene-derived analogs as sigma(1) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14: 2217-20. PMID 15081012 DOI: 10.1016/j.bmcl.2004.02.018 |
1 |
|
| 2004 |
Glennon RA, Ismaiel AM, Ablordeppey S, El-Ashmawy M, Fisher JB. Thioxanthene-derived analogs as sigma(1) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14: 2217-20. PMID 15081012 DOI: 10.1016/j.bmcl.2004.02.018 |
1 |
|
| 2004 |
Chang-Fong J, Rangisetty JB, Dukat M, Setola V, Raffay T, Roth B, Glennon RA. 1,2,3,4-Tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 1961-1964. PMID 15050637 DOI: 10.1016/j.bmcl.2004.01.071 |
1 |
|
| 2004 |
Chang-Fong J, Rangisetty JB, Dukat M, Setola V, Raffay T, Roth B, Glennon RA. 1,2,3,4-Tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 1961-1964. PMID 15050637 DOI: 10.1016/j.bmcl.2004.01.071 |
0.36 |
|
| 2004 |
Glennon RA, Dukat M. α4β2 nACh Receptor pharmacophore models Bioorganic and Medicinal Chemistry Letters. 14: 1841-1844. PMID 15050612 DOI: 10.1016/j.bmcl.2003.07.035 |
1 |
|
| 2004 |
Chang-Fong J, Tyacke RJ, Lau A, Westaway J, Hudson AL, Glennon RA. Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I2 receptor ligands Bioorganic and Medicinal Chemistry Letters. 14: 1003-1005. PMID 15013010 DOI: 10.1016/j.bmcl.2003.12.033 |
1 |
|
| 2004 |
Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of β-carbolines at imidazoline I2 receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry Letters. 14: 999-1002. PMID 15013009 DOI: 10.1016/j.bmcl.2003.11.078 |
1 |
|
| 2004 |
Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of β-carbolines at imidazoline I2 receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry Letters. 14: 999-1002. PMID 15013009 DOI: 10.1016/j.bmcl.2003.11.078 |
0.32 |
|
| 2004 |
Glennon RA. Medicinal Chemistry of α4β2 Nicotinic Cholinergic Receptor Ligands Progress in Medicinal Chemistry. 42: 55-123. PMID 15003719 DOI: 10.1016/S0079-6468(04)42002-5 |
1 |
|
| 2004 |
Glennon RA, Dukat M, Liao L. Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models. Current Topics in Medicinal Chemistry. 4: 631-44. PMID 14965299 |
0.64 |
|
| 2004 |
Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of an imidazopyridoindole at imidazoline I2 receptors Bioorganic and Medicinal Chemistry Letters. 14: 527-529. PMID 14698196 DOI: 10.1016/j.bmcl.2003.09.092 |
1 |
|
| 2004 |
Glennon RA, Grella B, Tyacke RJ, Lau A, Westaway J, Hudson AL. Binding of an imidazopyridoindole at imidazoline I2 receptors Bioorganic and Medicinal Chemistry Letters. 14: 527-529. PMID 14698196 DOI: 10.1016/j.bmcl.2003.09.092 |
0.32 |
|
| 2004 |
Dogruer D, Lee M, Dukat M, Damaj MI, Martin BR, Glennon RA. 3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors. Bioorganic & Medicinal Chemistry Letters. 14: 523-6. PMID 14698195 DOI: 10.1016/j.bmcl.2003.10.033 |
1 |
|
| 2004 |
Dogruer D, Lee M, Dukat M, Damaj MI, Martin BR, Glennon RA. 3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors. Bioorganic & Medicinal Chemistry Letters. 14: 523-6. PMID 14698195 DOI: 10.1016/j.bmcl.2003.10.033 |
1 |
|
| 2004 |
Glennon RA, Dukat M, Liao L. Musings on αβ2 nicotinic acetylcholine (nACh) receptor pharmacophore models Current Topics in Medicinal Chemistry. 4: 631-644. DOI: 10.2174/1568026043451122 |
1 |
|
| 2004 |
Glennon RA, Dukat M, Liao L. Musings on αβ2 nicotinic acetylcholine (nACh) receptor pharmacophore models Current Topics in Medicinal Chemistry. 4: 631-644. DOI: 10.2174/1568026043451122 |
0.64 |
|
| 2004 |
Giorgioni G, Piergentili A, Glennon RA. 14th Camerino Noordwijkerhout Symposium: (1978-2003, The Silver Symposium) Ongoing Progress in the Receptor Chemistry - September 7-11, 2003, Camerino, Italy. Guest editorial Medicinal Chemistry Research. 13: 127-130. DOI: 10.1007/s00044-004-0018-6 |
1 |
|
| 2004 |
Glennon RA. Nicotine and pain Medicinal Chemistry Research. 13: 74-77. DOI: 10.1007/s00044-004-0011-0 |
1 |
|
| 2004 |
Giorgioni G, Piergentili A, Glennon RA. Guest editorial Medicinal Chemistry Research. 13: 1. DOI: 10.1007/s00044-004-0001-2 |
1 |
|
| 2003 |
Tyacke RJ, Lau A, Grella B, Glennon RA, Nutt DJ, Hudson AL. Investigation of the Affinities of Two New β-Carbolines for Rat Brain Imidazoline2 Receptors Annals of the New York Academy of Sciences. 1009: 361-363. PMID 15028612 DOI: 10.1196/annals.1304.047 |
1 |
|
| 2003 |
Tyacke RJ, Lau A, Grella B, Glennon RA, Nutt DJ, Hudson AL. Investigation of the Affinities of Two New β-Carbolines for Rat Brain Imidazoline2 Receptors Annals of the New York Academy of Sciences. 1009: 361-363. PMID 15028612 DOI: 10.1196/annals.1304.047 |
0.32 |
|
| 2003 |
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. 482: 335-7. PMID 14660041 DOI: 10.1016/j.ejphar.2003.09.059 |
1 |
|
| 2003 |
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. 482: 335-7. PMID 14660041 DOI: 10.1016/j.ejphar.2003.09.059 |
1 |
|
| 2003 |
Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA. Binding of β-carbolines at 5-HT2 serotonin receptors Bioorganic and Medicinal Chemistry Letters. 13: 4421-4425. PMID 14643338 DOI: 10.1016/j.bmcl.2003.09.027 |
1 |
|
| 2003 |
Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA. Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 13: 2917-20. PMID 14611857 DOI: 10.1016/S0960-894X(03)00585-7 |
1 |
|
| 2003 |
Simsek R, Chang-Fong J, Lee M, Dukat M, Imad Damaj M, Martin BR, Glennon RA. Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents. Bioorganic & Medicinal Chemistry Letters. 13: 2917-20. PMID 14611857 DOI: 10.1016/S0960-894X(03)00585-7 |
1 |
|
| 2003 |
Glennon RA, Daoud MK, Dukat MS, Teitler M, Herrick-Davis K, Purohit A, Syed H. Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: A QSAR study Bioorganic and Medicinal Chemistry. 11: 4449-4454. PMID 13129581 DOI: 10.1016/S0968-0896(03)00488-7 |
1 |
|
| 2003 |
Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacology, Biochemistry, and Behavior. 75: 845-52. PMID 12957227 DOI: 10.1016/S0091-3057(03)00159-X |
1 |
|
| 2003 |
Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. The Journal of Pharmacology and Experimental Therapeutics. 307: 138-45. PMID 12954796 DOI: 10.1124/jpet.103.053975 |
1 |
|
| 2003 |
Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. The Journal of Pharmacology and Experimental Therapeutics. 307: 138-45. PMID 12954796 DOI: 10.1124/jpet.103.053975 |
1 |
|
| 2003 |
Pullagurla MR, Dukat M, Setola V, Roth B, Glennon RA. N1-benzenesulfonylgramine and N1-benzenesulfonylskatole: novel 5-HT6 receptor ligand templates. Bioorganic & Medicinal Chemistry Letters. 13: 3355-9. PMID 12951125 |
0.76 |
|
| 2003 |
Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors. Journal of Medicinal Chemistry. 46: 3930-7. PMID 12930153 DOI: 10.1021/jm030080s |
1 |
|
| 2003 |
Bondarev ML, Bondareva TS, Young R, Glennon RA. Behavioral and biochemical investigations of bupropion metabolites. European Journal of Pharmacology. 474: 85-93. PMID 12909199 DOI: 10.1016/S0014-2999(03)02010-7 |
1 |
|
| 2003 |
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor. Bioorganic & Medicinal Chemistry Letters. 13: 2565-8. PMID 12852967 DOI: 10.1016/S0960-894X(03)00504-3 |
1 |
|
| 2003 |
Glennon RA. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). Journal of Medicinal Chemistry. 46: 2795-812. PMID 12825922 DOI: 10.1021/jm030030n |
1 |
|
| 2003 |
Dukat M, Glennon RA. Epibatidine: impact on nicotinic receptor research. Cellular and Molecular Neurobiology. 23: 365-78. PMID 12825833 DOI: 10.1023/A:1023692705700 |
1 |
|
| 2003 |
Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Molecular Pharmacology. 63: 1223-9. PMID 12761331 DOI: 10.1124/mol.63.6.1223 |
1 |
|
| 2003 |
Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA. Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG). Bioorganic & Medicinal Chemistry Letters. 13: 1119-23. PMID 12643925 DOI: 10.1016/S0960-894X(03)00044-1 |
1 |
|
| 2003 |
Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors. Bioorganic & Medicinal Chemistry Letters. 13: 733-5. PMID 12639569 DOI: 10.1016/S0960-894X(02)01031-4 |
1 |
|
| 2003 |
Khorana N, Purohit A, Herrick-Davis K, Teitler M, Glennon RA. gamma-Carbolines: binding at 5-HT5A serotonin receptors. Bioorganic & Medicinal Chemistry. 11: 717-22. PMID 12538001 DOI: 10.1016/S0968-0896(02)00527-8 |
1 |
|
| 2003 |
Pullagurla MR, Dukat MS, Setola V, Roth B, Glennon RA. N1-benzenesulfonylgramine and N 1-benzenesulfonylskatole: Novel 5-HT6 receptor ligand templates Bioorganic and Medicinal Chemistry Letters. 13: 3355-3359. DOI: 10.1016/S0960-894X(03)00612-7 |
1 |
|
| 2003 |
Pullagurla MR, Dukat MS, Setola V, Roth B, Glennon RA. N1-benzenesulfonylgramine and N 1-benzenesulfonylskatole: Novel 5-HT6 receptor ligand templates Bioorganic and Medicinal Chemistry Letters. 13: 3355-3359. DOI: 10.1016/S0960-894X(03)00612-7 |
0.76 |
|
| 2002 |
Bondareva TS, Young R, Glennon RA. Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine. Pharmacology, Biochemistry, and Behavior. 74: 157-62. PMID 12376163 DOI: 10.1016/S0091-3057(02)00963-2 |
1 |
|
| 2002 |
Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding. Journal of Medicinal Chemistry. 45: 4724-31. PMID 12361399 DOI: 10.1021/jm020188s |
1 |
|
| 2002 |
Dukat M, El-Zahabi M, Ferretti G, Damaj MI, Martin BR, Young R, Glennon RA. (-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine. Bioorganic & Medicinal Chemistry Letters. 12: 3005-7. PMID 12270194 DOI: 10.1016/S0960-894X(02)00614-5 |
1 |
|
| 2002 |
Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA. A comparison of the binding of three series of nicotinic ligands. Bioorganic & Medicinal Chemistry Letters. 12: 1989-92. PMID 12113825 DOI: 10.1016/S0960-894X(02)00298-6 |
1 |
|
| 2002 |
Ablordeppey SY, Fischer JB, Law H, Glennon RA. Probing the proposed phenyl-A region of the sigma-1 receptor. Bioorganic & Medicinal Chemistry. 10: 2759-65. PMID 12057665 DOI: 10.1016/S0968-0896(02)00096-2 |
1 |
|
| 2002 |
Westkaemper RB, Glennon RA. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands. Current Topics in Medicinal Chemistry. 2: 575-98. PMID 12052195 |
1 |
|
| 2002 |
Glennon RA, Metwally K, Dukat M, Ismaiel AM, De los Angeles J, Herndon J, Teitler M, Khorana N. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists. Current Topics in Medicinal Chemistry. 2: 539-58. PMID 12052193 DOI: 10.1016/B978-008055232-3.61983-X |
1 |
|
| 2002 |
Young R, Glennon RA. Nicotine and bupropion share a similar discriminative stimulus effect. European Journal of Pharmacology. 443: 113-8. PMID 12044800 DOI: 10.1016/S0014-2999(02)01554-6 |
1 |
|
| 2002 |
Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Journal of Medicinal Chemistry. 45: 1656-64. PMID 11931619 DOI: 10.1021/jm010354g |
1 |
|
| 2002 |
Glennon RA, Young R, Rangisetty JB. Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline. Pharmacology, Biochemistry, and Behavior. 72: 379-87. PMID 11900809 DOI: 10.1016/S0091-3057(01)00768-7 |
1 |
|
| 2002 |
Glennon RA, Young R. Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats. Pharmacology, Biochemistry, and Behavior. 72: 307-11. PMID 11900801 DOI: 10.1016/S0091-3057(01)00770-5 |
1 |
|
| 2002 |
Dukat M, Young R, Glennon RA. Effect of PMA optical isomers and 4-MTA in PMMA-trained rats. Pharmacology, Biochemistry, and Behavior. 72: 299-305. PMID 11900800 DOI: 10.1016/S0091-3057(01)00776-6 |
1 |
|
| 2002 |
Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA. Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. European Journal of Pharmacology. 435: 171-80. PMID 11821023 DOI: 10.1016/S0014-2999(01)01570-9 |
1 |
|
| 2002 |
Young R, Glennon RA. The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline is similar to that of cocaine but different from that of amphetamine. Pharmacology, Biochemistry, and Behavior. 71: 205-13. PMID 11812524 DOI: 10.1016/S0091-3057(01)00666-9 |
1 |
|
| 2002 |
Chang-Fong J, Addo J, Dukat M, Smith C, Mitchell NA, Herrick-Davis K, Teitler M, Glennon RA. Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 12: 155-8. PMID 11755343 DOI: 10.1016/S0960-894X(01)00713-2 |
1 |
|
| 2002 |
Glennon RA. A final editorial Medicinal Chemistry Research. 11: v. |
1 |
|
| 2001 |
Hong SS, Young R, Glennon RA. Discriminative stimulus properties of alpha-ethyltryptamine optical isomers. Pharmacology, Biochemistry, and Behavior. 70: 311-6. PMID 11701202 DOI: 10.1016/S0091-3057(01)00605-0 |
1 |
|
| 2001 |
Rangisetty JB, Dukat M, Dowd CS, Herrick-Davis K, DuPre A, Gadepalli S, Teitler M, Kelley CR, Sharif NA, Glennon RA. 1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character. Journal of Medicinal Chemistry. 44: 3283-91. PMID 11563927 DOI: 10.1021/jm0100739 |
1 |
|
| 2001 |
Husbands SM, Glennon RA, Gorgerat S, Gough R, Tyacke R, Crosby J, Nutt DJ, Lewis JW, Hudson AL. beta-carboline binding to imidazoline receptors. Drug and Alcohol Dependence. 64: 203-8. PMID 11543990 DOI: 10.1016/S0376-8716(01)00123-5 |
1 |
|
| 2001 |
Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA. Pharmacology, Biochemistry, and Behavior. 69: 261-7. PMID 11420094 DOI: 10.1016/S0091-3057(01)00530-5 |
1 |
|
| 2001 |
Dukat M, Choi YN, Teitler M, Du Pre A, Herrick-Davis K, Smith C, Glennon RA. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation. Bioorganic & Medicinal Chemistry Letters. 11: 1599-603. PMID 11412989 DOI: 10.1016/S0960-894X(01)00291-8 |
1 |
|
| 2001 |
Prisinzano T, Law H, Dukat M, Slassi A, MaClean N, Demchyshyn L, Glennon RA. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands. Bioorganic & Medicinal Chemistry. 9: 613-9. PMID 11310595 DOI: 10.1016/S0968-0896(00)00275-3 |
1 |
|
| 2001 |
Runyon SP, Savage JE, Taroua M, Roth BL, Glennon RA, Westkaemper RB. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Bioorganic & Medicinal Chemistry Letters. 11: 655-8. PMID 11266163 DOI: 10.1016/S0960-894X(01)00023-3 |
1 |
|
| 2001 |
Westkaemper RB, Runyon SP, Savage JE, Roth BL, Glennon RA. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor. Bioorganic & Medicinal Chemistry Letters. 11: 563-6. PMID 11229772 DOI: 10.1016/S0960-894X(01)00010-5 |
1 |
|
| 2001 |
Prisinzano T, Law H, Slassi A, Maclean N, Demchyshyn L, Glennon RA. QSAR studies on 2-(benzyl)imidazoline analogs as h5-HT1D/1B serotonin receptor ligands Medicinal Chemistry Research. 10: 309-317. |
1 |
|
| 2000 |
Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA. Chain-lengthened and imidazoline analogues of nicotine. Bioorganic & Medicinal Chemistry Letters. 10: 2665-8. PMID 11128647 DOI: 10.1016/S0960-894X(00)00541-2 |
1 |
|
| 2000 |
Tsai Y, Dukat M, Slassi A, MacLean N, Demchyshyn L, Savage JE, Roth BL, Hufesein S, Lee M, Glennon RA. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 10: 2295-9. PMID 11055342 DOI: 10.1016/S0960-894X(00)00453-4 |
1 |
|
| 2000 |
Ablordeppey SY, Fischer JB, Glennon RA. Is a nitrogen atom an important pharmacophoric element in sigma ligand binding? Bioorganic & Medicinal Chemistry. 8: 2105-11. PMID 11003156 DOI: 10.1016/S0968-0896(00)00148-6 |
1 |
|
| 2000 |
Hellberg M, Stubbins JF, Glennon RA. A preliminary investigation of mesoionic xanthine analogues as inhibitors of platelet aggregation. Bioorganic & Medicinal Chemistry. 8: 1917-23. PMID 11003136 DOI: 10.1016/S0968-0896(00)00123-1 |
1 |
|
| 2000 |
Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists Journal of Medicinal Chemistry. 43: 3074-3084. PMID 10956215 DOI: 10.1021/jm9906062 |
1 |
|
| 2000 |
Glennon RA, Dukat M, Grella B, Hong SS, Costantino L, Teitler M, Smith C, Egan C, Davis K, Mattson MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5- HT(1A)), dopamine (D2) and benzodiazepine receptors Drug and Alcohol Dependence. 60: 121-132. PMID 10940539 DOI: 10.1016/S0376-8716(99)00148-9 |
1 |
|
| 2000 |
Dukat M, Young R, Darmani NN, Ahmed B, Glennon RA. The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay Psychopharmacology. 150: 200-207. PMID 10907673 DOI: 10.1007/s002130000410 |
1 |
|
| 2000 |
Young R, Glennon RA. Stimulus effects of phenylpropanolamine optical isomers in (+)amphetamine-trained rats Pharmacology Biochemistry and Behavior. 66: 489-494. PMID 10899360 DOI: 10.1016/S0091-3057(00)00173-8 |
1 |
|
| 2000 |
Glennon RA, Young R. MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin Pharmacology Biochemistry and Behavior. 66: 483-488. PMID 10899359 DOI: 10.1016/S0091-3057(00)00174-X |
1 |
|
| 2000 |
Kristiansen K, Kroeze WK, Willins DL, Gelber EI, Savage JE, Glennon RA, Roth BL. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism. The Journal of Pharmacology and Experimental Therapeutics. 293: 735-46. PMID 10869371 |
1 |
|
| 2000 |
Glennon RA, Young R. (+)Amphetamine-stimulus generalization to an herbal ephedrine product Pharmacology Biochemistry and Behavior. 65: 655-658. PMID 10764918 DOI: 10.1016/S0091-3057(99)00238-5 |
1 |
|
| 2000 |
Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. Journal of Medicinal Chemistry. 43: 1011-8. PMID 10715164 DOI: 10.1021/jm990550b |
1 |
|
| 2000 |
Glennon RA, Dukat M. Central nicotinic receptor ligands and pharmacophores Pharmacochemistry Library. 31: 103-114. DOI: 10.1016/S0165-7208(00)80006-9 |
1 |
|
| 2000 |
Lee M, Rangisetty JB, Dukat M, Slassi A, Maclean N, Lee DKH, Glennon RA. 5-HT6 serotonin receptor binding affinities of N1-benzenesulfonyl and related tryptamines Medicinal Chemistry Research. 10: 230-242. |
1 |
|
| 1999 |
Young R, Bondarev M, Glennon RA. An examination of isomeric phenylpropanolamines in (-)ephedrine-trained rats Drug and Alcohol Dependence. 57: 1-6. PMID 10617308 DOI: 10.1016/S0376-8716(99)00052-6 |
1 |
|
| 1999 |
Young R, Dukat M, Malmusi L, Glennon RA. Stimulus properties of PMMA: Effect of optical isomers and conformational restriction Pharmacology Biochemistry and Behavior. 64: 449-453. PMID 10515329 DOI: 10.1016/S0091-3057(99)00060-X |
1 |
|
| 1999 |
Glennon RA. Arylalkylamine drugs of abuse: An overview of drug discrimination studies Pharmacology Biochemistry and Behavior. 64: 251-256. PMID 10515299 DOI: 10.1016/S0091-3057(99)00045-3 |
1 |
|
| 1999 |
Westkaemper RB, Runyon SP, Bondarev ML, Savage JE, Roth BL, Glennon RA. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist. European Journal of Pharmacology. 380: R5-7. PMID 10513561 DOI: 10.1016/S0014-2999(99)00525-7 |
1 |
|
| 1999 |
Flammia D, Dukat M, Damaj MI, Martin B, Glennon RA. Lobeline: Structure-affinity investigation of nicotinic acetylcholinergic receptor binding Journal of Medicinal Chemistry. 42: 3726-3731. PMID 10479304 DOI: 10.1021/jm990286m |
1 |
|
| 1999 |
Nelson DL, Lucaites VL, Wainscott DB, Glennon RA. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 359: 1-6. PMID 9933142 |
1 |
|
| 1999 |
Westkaemper RB, Hyde EG, Choudhary MS, Khan N, Gelbar EI, Glennon RA, Roth BL. Engineering a region of bulk tolerance in the 5-ht(2a) receptor European Journal of Medicinal Chemistry. 34: 441-447. DOI: 10.1016/S0223-5234(99)80094-4 |
1 |
|
| 1999 |
Cheng YX, Dukat M, Dowd M, Fiedler W, Martin B, Damaj MI, Glennon RA. Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-opened analogs at central nicotinic receptors European Journal of Medicinal Chemistry. 34: 177-190. DOI: 10.1016/S0223-5234(99)80051-8 |
1 |
|
| 1999 |
Dukat M, Dowd M, Damaj MI, Martin B, El-Zahabi MA, Glennon RA. Synthesis, receptor binding and QSAR studies on 6-substituted nicotine derivatives as cholinergic ligands European Journal of Medicinal Chemistry. 34: 31-40. DOI: 10.1016/S0223-5234(99)80038-5 |
1 |
|
| 1999 |
Hong S, Dukat M, Teitler M, Egan C, Dupre A, Herrick-Davis K, Glennon RA. 5,8-Dimethoxyharmalan: Actions at 5-HT(2A) serotonin receptors Medicinal Chemistry Research. 9: 374-388. |
1 |
|
| 1999 |
Khorana N, Bondarev M, Dukat M, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. Binding of spiperone analogs at 5-HT(2A) serotonin receptors Medicinal Chemistry Research. 9: 657-667. |
1 |
|
| 1999 |
Glennon RA, Bondarev M, Roth B. 5-HT6 serotonin receptor binding of indolealkylamines: A preliminary structure-affinity investigation Medicinal Chemistry Research. 9: 108-117. |
1 |
|
| 1998 |
Young R, Glennon RA. Discriminative stimulus effects of S(-)-methcathinone (CAT): A potent stimulant drug of abuse Psychopharmacology. 140: 250-256. PMID 9877004 DOI: 10.1007/s002130050765 |
1 |
|
| 1998 |
Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA. Spiperone: Influence of spiro ring substituents on 5-HT(2A) serotonin receptor binding Journal of Medicinal Chemistry. 41: 5084-5093. PMID 9836624 DOI: 10.1021/jm980452a |
1 |
|
| 1998 |
Young R, Gabryszuk M, Glennon RA. (-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects Pharmacology Biochemistry and Behavior. 61: 169-173. PMID 9738532 DOI: 10.1016/S0091-3057(98)00044-6 |
1 |
|
| 1998 |
Young R, Glennon RA. Discriminative stimulus properties of (-)ephedrine Pharmacology Biochemistry and Behavior. 60: 771-775. PMID 9678664 DOI: 10.1016/S0091-3057(98)00055-0 |
1 |
|
| 1998 |
Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB, Glennon RA. Investigation of hallucinogenic and related β-carbolines Drug and Alcohol Dependence. 50: 99-107. PMID 9649961 DOI: 10.1016/S0376-8716(97)00163-4 |
1 |
|
| 1998 |
Law H, Dukat M, Teitler M, Lee DKH, Mazzocco L, Kamboj R, Rampersad V, Prisinzano T, Glennon RA. Benzylimidazolines as h5-HT(1B/1D) serotonin receptor ligands: A structure-affinity investigation Journal of Medicinal Chemistry. 41: 2243-2251. PMID 9632357 DOI: 10.1021/jm970513p |
1 |
|
| 1998 |
Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M. Agonist activity of LSD and lisuride at cloned 5HT(2A) and 5HT(2C) receptors Psychopharmacology. 136: 409-414. PMID 9600588 DOI: 10.1007/s002130050585 |
1 |
|
| 1998 |
Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. The Journal of Pharmacology and Experimental Therapeutics. 284: 1058-65. PMID 9495867 |
1 |
|
| 1998 |
Ablordeppey SY, El-Ashmawy M, Fischer JB, Glennon RA. A CoMFA investigation of sigma receptor binding affinity: Reexamination of a spurious sigma ligand European Journal of Medicinal Chemistry. 33: 625-633. DOI: 10.1016/S0223-5234(98)80021-4 |
1 |
|
| 1998 |
Bondarev M, Iwamura T, Hynd D, Mazzocco L, Lee DKH, Dukat M, Glennon RA. Aryloxyethylamines as h5-HT(1D) serotonin receptor ligands Medicinal Chemistry Research. 8: 333-342. |
1 |
|
| 1997 |
Ismaiel AM, Dukat M, Law H, Kamboj R, Fan E, Lee DKH, Mazzocco L, Buekschkens D, Teitler M, Pierson ME, Glennon RA. 2-(1-naphthyloxy)ethylamines with enhanced affinity for human 5-HT(1Dβ) (h5-HT(1B)) serotonin receptors Journal of Medicinal Chemistry. 40: 4415-4419. PMID 9435911 DOI: 10.1021/jm970507t |
1 |
|
| 1997 |
Dal Cason TA, Young R, Glennon RA. Cathinone: An investigation of several N-alkyl and methylenedioxy-substituted analogs Pharmacology Biochemistry and Behavior. 58: 1109-1116. PMID 9408221 DOI: 10.1016/S0091-3057(97)00323-7 |
1 |
|
| 1997 |
Glennon RA, Young R, Dukat M, Cheng Y. Initial characterization of PMMA as a discriminative stimulus Pharmacology Biochemistry and Behavior. 57: 151-158. PMID 9164566 DOI: 10.1016/S0091-3057(96)00306-1 |
1 |
|
| 1997 |
Young R, Glennon RA. Cocaine - Stimulus generalization to MDA optical isomores: A reevaluation Pharmacology Biochemistry and Behavior. 57: 115-118. PMID 9164561 DOI: 10.1016/S0091-3057(96)00352-8 |
1 |
|
| 1997 |
Young R, Darmani NA, Elder EL, Dumas D, Glennon RA. Clobenzorex: Evidence for amphetamine-like behavioral actions Pharmacology Biochemistry and Behavior. 56: 311-316. PMID 9050090 DOI: 10.1016/S0091-3057(96)00329-2 |
1 |
|
| 1997 |
Teitler M, Scheick C, Howard P, Sullivan JE, Iwamura T, Glennon RA. 5-HT5A serotonin receptor binding: A preliminary structure-affinity investigation Medicinal Chemistry Research. 7: 207-218. |
1 |
|
| 1996 |
Dukat M, Abdel-Rahman AA, Ismaiel AM, Ingher S, Teitler M, Gyermek L, Glennon RA. Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors Journal of Medicinal Chemistry. 39: 4017-4026. PMID 8831767 DOI: 10.1021/jm9603936 |
1 |
|
| 1996 |
Young R, Glennon RA. A three-lever operant procedure differentiates the stimulus effects of R(-)-MDA from S(+)-MDA Journal of Pharmacology and Experimental Therapeutics. 276: 594-601. PMID 8632326 |
1 |
|
| 1996 |
Glennon RA, Dukat M, Westkaemper RB, Ismaiel AM, Izzarelli DG, Parker EM. The binding of propranolol at 5-hydroxytryptamine1Dβ T355N mutant receptors may involve formation of two hydrogen bonds to asparagine Molecular Pharmacology. 49: 198-206. PMID 8569707 |
1 |
|
| 1996 |
Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhit S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C. Binding of O-alkyl derivatives of serotonin at human 5-HT1Dβ receptors Journal of Medicinal Chemistry. 39: 314-322. PMID 8568822 DOI: 10.1021/jm950498t |
1 |
|
| 1996 |
Dukat M, Fiedler W, Dumas D, Damaj I, Martin BR, Rosecrans JA, James JR, Glennon RA. Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation European Journal of Medicinal Chemistry. 31: 875-888. DOI: 10.1016/S0223-5234(97)89850-9 |
1 |
|
| 1996 |
Imad Damaj M, Glassco W, Dukat M, May EL, Glennon RA, Martin BR. Pharmacology of novel nicotinic analogs Drug Development Research. 38: 177-187. DOI: 10.1002/(SICI)1098-2299(199607/08)38:3/4<177::AID-DDR6>3.0.CO;2-J |
1 |
|
| 1996 |
Malmusi L, Dukat M, Young R, Teitler M, Darmani NA, Ahmad B, Smith C, Glennon RA. 1,2,3,4-Tetrahydroisoquinoline analogs of phenylalkylamine stimulants and hallucinogens Medicinal Chemistry Research. 6: 400-411. |
1 |
|
| 1996 |
Ismaiel AM, Dukat M, Nelson DL, Lucaites VL, Glennon RA. Binding of N2-substituted pyrido[4,3-b]indole analogs of spiperone at human 5-HT2A, 5-HT2B, and 5-HT2C serotonin receptors Medicinal Chemistry Research. 6: 197-211. |
1 |
|
| 1996 |
Glennon RA, Dukat M. Nicotine receptor ligands Medicinal Chemistry Research. 6: 465-486. |
1 |
|
| 1996 |
Malmusi L, Dukat M, Young R, Teitler M, Darmani NA, Ahmad B, Smith C, Glennon RA. 1,2,3,4-Tetrahydroisoquinoline and related analogs of the phenylalkylamine designer drug MDMA Medicinal Chemistry Research. 6: 412-426. |
1 |
|
| 1996 |
Iwamura T, Casey CT, Young R, Dukat M, Teitler M, Fadden JSP, Glennon RA. 4-(6-Fluorobenzisoxazol-3-yl)piperidine, a risperidone metabolite with serotonergic activity of potential clinical significance Medicinal Chemistry Research. 6: 593-601. |
1 |
|
| 1995 |
Ismaiel AM, Arruda K, Teitler M, Glennon RA. Ketanserin analogues: The effect of structural modification on 5-HT2 serotonin receptor binding Journal of Medicinal Chemistry. 38: 1196-1202. PMID 7707322 |
1 |
|
| 1995 |
Choudhary MS, Sachs N, Uluer A, Glennon RA, Westkaemper RB, Roth BL. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Molecular Pharmacology. 47: 450-7. PMID 7700242 |
1 |
|
| 1995 |
Glennon RA, Young R, Martin BR, Dal Cason TA. Methcathinone ("cat"): An enantiomeric potency comparison Pharmacology, Biochemistry and Behavior. 50: 601-606. PMID 7617707 DOI: 10.1016/0091-3057(94)00348-3 |
1 |
|
| 1994 |
Westkaemper RB, Glennon RA. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors Nida Research Monograph. 146: 263-283. PMID 8742803 |
1 |
|
| 1994 |
Glennon RA, Ablordeppey SY, Ismaiel AM, el-Ashmawy MB, Fischer JB, Howie KB. Structural features important for sigma 1 receptor binding. Journal of Medicinal Chemistry. 37: 1214-9. PMID 8164264 |
1 |
|
| 1994 |
Glennon RA, Hong SS, Dukat M, Teitler M, Davis K. 5-(Nonyloxy)tryptamine: A novel high-affinity 5-HTIDβ serotonin receptor agonist Journal of Medicinal Chemistry. 37: 2828-2830. PMID 8071931 DOI: 10.1021/JM00044A001 |
1 |
|
| 1994 |
Glennon RA, Dukat M, El-Bermawy M, Law H, De Los Angeles J, Teitler M, King A, Herrick-Davis K. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines Journal of Medicinal Chemistry. 37: 1929-1935. PMID 8027974 |
1 |
|
| 1994 |
Carroll FI, Glennon RA, Johnson MR, Teitler M, Zimmerman DM. Hallucinogenic agents: Drugs of abuse as neurochemical tools Nida Research Monograph Series. 94-98. |
1 |
|
| 1994 |
Glennon RA. Hallucinogens: An update. Summary Nida Research Monograph Series. 298-301. |
1 |
|
| 1993 |
Ismaiel AM, De Los Angeles J, Teitler M, Ingher S, Glennon RA. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist Journal of Medicinal Chemistry. 36: 2519-2525. PMID 8355253 DOI: 10.1021/JM00069A010 |
1 |
|
| 1993 |
Glennon RA, Young R, Herndon JL. Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs Pharmacology, Biochemistry and Behavior. 45: 865-869. PMID 8105490 DOI: 10.1016/0091-3057(93)90133-E |
1 |
|
| 1992 |
Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. Journal of Medicinal Chemistry. 35: 734-40. PMID 1542100 DOI: 10.1021/JM00082A014 |
1 |
|
| 1992 |
Herndon JL, Ismaiel A, Ingher SP, Teitler M, Glennon RA. Ketanserin analogues: Structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding Journal of Medicinal Chemistry. 35: 4903-4910. PMID 1479590 DOI: 10.1021/JM00104A017 |
1 |
|
| 1992 |
Herndon JL, Pierson ME, Glennon RA. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine Pharmacology, Biochemistry and Behavior. 43: 739-748. PMID 1333084 DOI: 10.1016/0091-3057(92)90403-3 |
1 |
|
| 1991 |
Glennon RA, Smith JD, Ismaiel AM, el-Ashmawy M, Battaglia G, Fischer JB. Identification and exploitation of the sigma-opiate pharmacophore. Journal of Medicinal Chemistry. 34: 1094-8. PMID 1848295 DOI: 10.1021/JM00107A033 |
1 |
|
| 1991 |
Westkaemper RB, Glennon RA. Approaches to molecular modeling studies and specific application to serotonin ligands and receptors Pharmacology, Biochemistry and Behavior. 40: 1019-1031. PMID 1816556 DOI: 10.1016/0091-3057(91)90122-I |
1 |
|
| 1991 |
Glennon RA, Yousif MY, Ismaiel AM, el-Ashmawy MB, Herndon JL, Fischer JB, Server AC, Howie KJ. Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity sigma ligands. Journal of Medicinal Chemistry. 34: 3360-5. PMID 1662725 DOI: 10.1021/JM00116A003 |
1 |
|
| 1991 |
Raghupathi RK, Rydelek-Fitzgerald L, Teitler M, Glennon RA. Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity. Journal of Medicinal Chemistry. 34: 2633-8. PMID 1652026 DOI: 10.1021/JM00112A043 |
1 |
|
| 1990 |
Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats. Drug and Alcohol Dependence. 26: 127-35. PMID 1978707 DOI: 10.1016/0376-8716(90)90119-Y |
1 |
|
| 1990 |
Glennon RA, Battaglia G, Smith JD. (-)PPAP: A new and selective ligand for sigma binding sites Pharmacology, Biochemistry and Behavior. 37: 557-559. PMID 1965044 DOI: 10.1016/0091-3057(90)90027-F |
1 |
|
| 1989 |
Fitzgerald RL, Blanke RV, Glennon RA, Yousif MY, Rosecrans JA, Poklis A. Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood. Journal of Chromatography. 490: 59-69. PMID 2760158 DOI: 10.1016/S0378-4347(00)82761-9 |
1 |
|
| 1989 |
Fitzgerald RL, Blanke RV, Rosecrans JA, Glennon RA. Stereochemistry of the metabolism of MDMA to MDA. Life Sciences. 45: 295-301. PMID 2569654 DOI: 10.1016/0024-3205(89)90138-0 |
1 |
|
| 1989 |
Sadzot B, Baraban JM, Glennon RA, Lyon RA, Leonhardt S, Jan CR, Titeler M. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis. Psychopharmacology. 98: 495-9. PMID 2505289 DOI: 10.1007/BF00441948 |
1 |
|
| 1987 |
Young R, Glennon RA, Dewey WL. Effects of pyrazolopyridines and a triazolopyridazine on the pentobarbital discriminative stimulus. Psychopharmacology. 93: 494-7. PMID 2893416 DOI: 10.1007/BF00207241 |
1 |
|
| 1987 |
Rosecrans JA, Glennon RA. The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice. Pharmacology, Biochemistry, and Behavior. 28: 39-42. PMID 2889221 DOI: 10.1016/0091-3057(87)90008-6 |
1 |
|
| 1987 |
Glennon RA, Little PJ, Rosecrans JA, Yousif M. The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice. Pharmacology, Biochemistry, and Behavior. 26: 425-6. PMID 2883666 DOI: 10.1016/0091-3057(87)90141-9 |
1 |
|
| 1986 |
Rasmussen K, Glennon RA, Aghajanian GK. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity. European Journal of Pharmacology. 132: 79-82. PMID 3816969 DOI: 10.1016/0014-2999(86)90014-2 |
1 |
|
| 1986 |
Young R, Rosecrans JA, Glennon RA. Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine. Pharmacology, Biochemistry, and Behavior. 25: 1207-10. PMID 3809222 DOI: 10.1016/0091-3057(86)90113-9 |
1 |
|
| 1986 |
Young R, Glennon RA, Brase DA, Dewey WL. Potencies of diazepam metabolites in rats trained to discriminate diazepam. Life Sciences. 39: 17-20. PMID 3088348 DOI: 10.1016/0024-3205(86)90432-7 |
1 |
|
| 1984 |
Aceto MD, Rosecrans JA, Young R, Glennon RA. Similarity between (+)-amphetamine and amfonelic acid. Pharmacology, Biochemistry, and Behavior. 20: 635-7. PMID 6728880 DOI: 10.1016/0091-3057(84)90316-2 |
1 |
|
| 1984 |
Schechter MD, Rosecrans JA, Glennon RA. Comparison of behavioral effects of cathinone, amphetamine and apomorphine. Pharmacology, Biochemistry, and Behavior. 20: 181-4. PMID 6718445 DOI: 10.1016/0091-3057(84)90238-7 |
1 |
|
| 1984 |
Shannon M, Battaglia G, Glennon RA, Titeler M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinugen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA) European Journal of Pharmacology. 102: 23-29. PMID 6479216 DOI: 10.1016/0014-2999(84)90333-9 |
1 |
|
| 1984 |
Glennon RA, Schechter MD, Rosecrans JA. Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)-cathine and several structural modifications. Pharmacology, Biochemistry, and Behavior. 21: 1-3. PMID 6463083 DOI: 10.1016/0091-3057(84)90121-7 |
1 |
|
| 1984 |
Young R, Glennon RA, Dewey WL. Stereoselective stimulus effects of 3-methylflunitrazepam and pentobarbital. Life Sciences. 34: 1977-83. PMID 6328149 DOI: 10.1016/0024-3205(84)90129-2 |
1 |
|
| 1984 |
Glennon RA, Tejani-Butt SM, Padgett W, Daly JW. Mesoionic xanthine analogues: antagonists of adenosine receptors. Journal of Medicinal Chemistry. 27: 1364-7. PMID 6090665 |
1 |
|
| 1983 |
Glennon RA, Young R, Rosecrans JA. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. European Journal of Pharmacology. 91: 189-96. PMID 6617740 DOI: 10.1016/0014-2999(83)90464-8 |
1 |
|
| 1983 |
Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines. European Journal of Pharmacology. 86: 453-9. PMID 6572591 DOI: 10.1016/0014-2999(83)90196-6 |
1 |
|
| 1983 |
Young R, Rosecrans JA, Glennon RA. Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105. Psychopharmacology. 80: 156-60. PMID 6410445 DOI: 10.1007/BF00427960 |
1 |
|
| 1983 |
Glennon RA, Rosecrans JA, Young R. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Medicinal Research Reviews. 3: 289-340. PMID 6350763 DOI: 10.1002/MED.2610030305 |
1 |
|
| 1982 |
Young R, Rosecrans JA, Glennon RA. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD. Life Sciences. 30: 2057-62. PMID 7109835 DOI: 10.1016/0024-3205(82)90446-5 |
1 |
|
| 1982 |
Glennon RA, Young R, Rosecrans JA. A comparison of the behavioral effects of DOM homologs. Pharmacology, Biochemistry, and Behavior. 16: 557-9. PMID 7071089 DOI: 10.1016/0091-3057(82)90414-2 |
1 |
|
| 1982 |
Glennon RA, Young R, Rosecrans JA. Discriminative stimulus properties of DOM and several molecular modifications. Pharmacology, Biochemistry, and Behavior. 16: 553-6. PMID 7071088 DOI: 10.1016/0091-3057(82)90413-0 |
1 |
|
| 1982 |
Glennon RA, Rosecrans JA. Indolealkylamine and phenalkylamine hallucinogens: a brief overview. Neuroscience and Biobehavioral Reviews. 6: 489-97. PMID 6757811 DOI: 10.1016/0149-7634(82)90030-6 |
1 |
|
| 1981 |
Glennon RA, Rosecrans JA, Young R. Behavioral properties of psychoactive phenylisopropylamines in rats. European Journal of Pharmacology. 76: 353-60. PMID 7327208 DOI: 10.1016/0014-2999(81)90106-0 |
1 |
|
| 1981 |
Glennon RA, Rosecrans JA. Speculations on the mechanism of action of hallucinogenic indolealkylamines. Neuroscience and Biobehavioral Reviews. 5: 197-207. PMID 7022271 DOI: 10.1016/0149-7634(81)90002-6 |
1 |
|
| 1980 |
Glennon RA, Liebowitz SM, Leming-Doot D, Rosecrans JA. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities. Journal of Medicinal Chemistry. 23: 990-4. PMID 7411554 DOI: 10.1021/JM00183A006 |
1 |
|
| 1980 |
Glennon RA, Schubert E, Jacyno JM, Rosecrans JA. Studies on several 7-substituted N,N-dimethyltryptamines. Journal of Medicinal Chemistry. 23: 1222-6. PMID 6779006 DOI: 10.1021/JM00185A014 |
1 |
|
| 1980 |
Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities. Psychopharmacology. 68: 155-8. PMID 6776558 DOI: 10.1007/BF00432133 |
1 |
|
| 1979 |
Glennon RA, Gessner PK, Godse DD, Kline BJ. Bufotenine esters Journal of Medicinal Chemistry. 22: 1414-1416. PMID 533890 DOI: 10.1021/jm00197a025 |
1 |
|
| 1979 |
Rosecrans JA, Glennon RA. Drug-induced cues in studying mechanisms of drug action. Neuropharmacology. 18: 981-9. PMID 530379 DOI: 10.1016/0028-3908(79)90162-X |
1 |
|
| 1979 |
Glennon RA, Gessner PK. Serotonin receptor binding affinities of tryptamine analogues Journal of Medicinal Chemistry. 22: 428-432. PMID 430481 DOI: 10.1021/JM00190A014 |
1 |
|
| 1979 |
Glennon RA, Rosecrans JA, Young R, Gaines J. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus. Life Sciences. 24: 993-7. PMID 286864 DOI: 10.1016/0024-3205(79)90317-5 |
1 |
|
| 1974 |
Coburn RA, Glennon RA, Chmielewicz ZF. Mesoionic purinone analogs. 7. In vitro antibacterial activity of mesoionic1,3,4-thiadiazolo[3,2-a]pyrimidme-5,7-diones Journal of Medicinal Chemistry. 17: 1025-1027. PMID 4213245 |
1 |
|
| 1973 |
Coburn RA, Glennon RA. Mesoionic purinone analogs. IV: Synthesis and in vitro antibacterial properties of mesoionic thiazolo[3,2 α]pyrimidin 5,7 diones and mesoionic 1,3,4 thiadiazolo[3,2 α]pyrimidin 5,7 diones Journal of Pharmaceutical Sciences. 62: 1785-1789. PMID 4202220 DOI: 10.1002/JPS.2600621110 |
1 |
|
| Show low-probability matches. |
